Pulmonology
From the Journals
Interstitial lung disease plus pulmonary hypertension equals poor outcomes in systemic sclerosis
Female sex and higher body mass index were associated with lower mortality risk.
Conference Coverage
Expert calls for sparing oxygen use for dyspnea in the emergency department
Oxygen therapy is used too often in patients with respiratory difficulties, says one expert.
From the Journals
Healthy babies can still get very sick from RSV
The study challenges the assumption that only infirm children are at risk for the worst outcomes from RSV.
News from the FDA/CDC
FDA warns AstraZeneca over ‘misleading claims’ about COPD drug
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
Conference Coverage
GERD with bronchiectasis: New invasive interventions show benefit
Invasive interventions show promise in the adjunctive control of bronchiectasis and other lung diseases with GERD.
Feature
AI in pulmonary medicine – imaging and beyond
Emerging artificial intelligence tools in pulmonology are crunching electronic records and physiological signals to improve predictive models.
Networks
DPP1 a promising target for bronchiectasis
Bronchiectasis is a chronic inflammatory lung disease characterized by the progressive destruction of the airways.
Pulmonary Perspectives®
Which biologic therapy should I use in patients who have moderate to severe asthma with associated comorbidities?
As new treatments for specific moderate to severe asthma phenotypes have been developed, management decisions have grown more complicated.
Latest News
Generic inhalers for COPD support hold their own
“I don’t see a clinical reason why one would ever need to get the brand name over the generic version.”
From the Journals
COPD plus PRISm may promote frailty progression
Frailty progression was significantly accelerated in patients with PRISm and COPD.